Cargando…
Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort †
SIMPLE SUMMARY: It is well known for gastric cancer patients with subtype of diffuse histology that a proportion of patients harbour an increased familial risk. Some patients and relatives even may be detected through a genetic testing. More precise studies about the frequency of hereditary criteria...
Autores principales: | Schölzchen, Jan, Treese, Christoph, Thuss-Patience, Peter, Mrózek, Alicja, Rau, Beate, Seeliger, Hendrik, Hartmann, Dirk, Estevéz-Schwarz, Lope, Siegmund, Britta, Horn, Denise, Nassir, Mani, Daum, Severin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330468/ https://www.ncbi.nlm.nih.gov/pubmed/35892851 http://dx.doi.org/10.3390/cancers14153590 |
Ejemplares similares
-
Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations
por: Treese, Christoph, et al.
Publicado: (2022) -
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
por: Treese, Christoph, et al.
Publicado: (2022) -
Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b
por: Volz, Magdalena Sarah, et al.
Publicado: (2015) -
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas
por: Treese, Christoph, et al.
Publicado: (2022) -
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
por: Ballhausen, Alexej, et al.
Publicado: (2022)